PH18605A - 3(methylthiomethyl,methylsulphinylmethyl or methylsulphonymethyl) 4 quinolines and therapeutic compositions - Google Patents

3(methylthiomethyl,methylsulphinylmethyl or methylsulphonymethyl) 4 quinolines and therapeutic compositions

Info

Publication number
PH18605A
PH18605A PH26202A PH26202A PH18605A PH 18605 A PH18605 A PH 18605A PH 26202 A PH26202 A PH 26202A PH 26202 A PH26202 A PH 26202A PH 18605 A PH18605 A PH 18605A
Authority
PH
Philippines
Prior art keywords
methylsulphonymethyl
methylsulphinylmethyl
quinolines
methylthiomethyl
therapeutic compositions
Prior art date
Application number
PH26202A
Other languages
English (en)
Inventor
Roy Victor Davies
Original Assignee
Boots Co Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boots Co Plc filed Critical Boots Co Plc
Publication of PH18605A publication Critical patent/PH18605A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/233—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/18—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/24—Oxygen atoms attached in position 8
    • C07D215/26—Alcohols; Ethers thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/36—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Quinoline Compounds (AREA)
PH26202A 1980-09-26 1981-09-14 3(methylthiomethyl,methylsulphinylmethyl or methylsulphonymethyl) 4 quinolines and therapeutic compositions PH18605A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB8031106 1980-09-26
GB8031162 1980-09-26
GB8118879 1981-06-19
GB8119062 1981-06-19

Publications (1)

Publication Number Publication Date
PH18605A true PH18605A (en) 1985-08-21

Family

ID=27449208

Family Applications (1)

Application Number Title Priority Date Filing Date
PH26202A PH18605A (en) 1980-09-26 1981-09-14 3(methylthiomethyl,methylsulphinylmethyl or methylsulphonymethyl) 4 quinolines and therapeutic compositions

Country Status (25)

Country Link
US (2) US4442109A (xx)
AT (1) AT379388B (xx)
AU (1) AU549078B2 (xx)
BG (2) BG36495A3 (xx)
CA (1) CA1146943A (xx)
CH (1) CH650254A5 (xx)
DD (1) DD201890A5 (xx)
DE (1) DE3138121A1 (xx)
DK (1) DK152674C (xx)
ES (2) ES505786A0 (xx)
FI (1) FI812997L (xx)
FR (1) FR2491064A1 (xx)
GR (1) GR75797B (xx)
IE (1) IE51542B1 (xx)
IL (1) IL63845A (xx)
IT (1) IT1189449B (xx)
LU (1) LU83649A1 (xx)
NL (1) NL8104394A (xx)
NO (1) NO154052C (xx)
NZ (1) NZ198414A (xx)
PH (1) PH18605A (xx)
PT (1) PT73666B (xx)
RO (2) RO82014A (xx)
SE (1) SE457533B (xx)
YU (2) YU230181A (xx)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT79031B (en) * 1983-08-20 1986-08-22 Boots Co Plc Therapeutic agents
EP0149519B1 (en) * 1984-01-13 1990-06-27 The Boots Company PLC Use of quinolones for the manufacture of a composition for the treatment of heart failure.
EP0172004B1 (en) * 1984-08-15 1990-03-21 The Boots Company PLC Quinolinones, process for their preparation and pharmaceutical compositions containing them
GB8515209D0 (en) * 1985-06-15 1985-07-17 Boots Co Plc Therapeutic agents
GB8515207D0 (en) * 1985-06-15 1985-07-17 Boots Co Plc Therapeutic agents
GB8627698D0 (en) * 1986-11-20 1986-12-17 Boots Co Plc Therapeutic agents
GB8726950D0 (en) * 1987-11-18 1987-12-23 Boots Co Plc Chemical process
GB8804016D0 (en) * 1988-02-22 1988-03-23 Boots Co Plc Therapeutic agents

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3121725A (en) * 1960-07-18 1964-02-18 Phillips Petroleum Co N-heterocyclic sulfides, sulfoxides, sulfones, and n-oxides of said sulfoxides and sulfones
US3801644A (en) * 1971-08-25 1974-04-02 Warner Lambert Co Substituted-o-hydroxy-omega-(methylsulfinyl)acetophenones and process for producing same
US3772301A (en) * 1971-11-22 1973-11-13 Warner Lambert Co (4-substituted)4-(methylsulfinyl)methylcarbostyrils
US4343805A (en) * 1978-12-16 1982-08-10 John Wyeth & Brother Limited Heterocyclic compounds
GB2038825B (en) * 1978-12-16 1983-02-09 Wyeth John & Brother Ltd Heterocyclic compounds substituted by heterocyclyl-alkyl-thio groups
ZA801575B (en) * 1979-03-27 1981-03-25 Boots Co Ltd Therapeutic agents
NZ193167A (en) * 1979-03-27 1984-08-24 Boots Co Plc Quinoline derivatives and pharmaceutical compositions
US4302360A (en) * 1980-01-11 1981-11-24 Agency Of Industrial Science & Technology Catalyst for catalytic combustion of hydrogen

Also Published As

Publication number Publication date
RO82014B (ro) 1983-05-30
DK152674C (da) 1988-08-22
IE51542B1 (en) 1987-01-07
SE457533B (sv) 1989-01-09
RO85318A (ro) 1984-09-29
IE812033L (en) 1982-03-02
FR2491064B1 (xx) 1984-03-16
RO82014A (ro) 1983-06-01
FR2491064A1 (fr) 1982-04-02
BG36495A3 (en) 1984-11-15
DK424781A (da) 1982-03-27
ES8302662A1 (es) 1982-12-01
ATA412181A (de) 1985-05-15
IT1189449B (it) 1988-02-04
BG36344A3 (en) 1984-10-15
AT379388B (de) 1985-12-27
SE8105689L (sv) 1982-03-27
CA1146943A (en) 1983-05-24
NL8104394A (nl) 1982-04-16
IL63845A0 (en) 1981-12-31
YU230181A (en) 1983-12-31
GR75797B (xx) 1984-08-02
YU144683A (en) 1983-12-31
NO813263L (no) 1982-03-29
ES514411A0 (es) 1983-05-01
NO154052C (no) 1986-07-16
DD201890A5 (de) 1983-08-17
AU7552481A (en) 1982-04-01
US4447435A (en) 1984-05-08
US4442109A (en) 1984-04-10
PT73666B (en) 1982-11-22
DK152674B (da) 1988-04-11
CH650254A5 (fr) 1985-07-15
RO85318B (ro) 1984-10-30
IL63845A (en) 1985-02-28
IT8149370A0 (it) 1981-09-25
NZ198414A (en) 1983-11-18
ES8306111A1 (es) 1983-05-01
LU83649A1 (fr) 1983-02-22
ES505786A0 (es) 1982-12-01
NO154052B (no) 1986-04-01
PT73666A (en) 1981-10-01
FI812997L (fi) 1982-03-27
AU549078B2 (en) 1986-01-16
DE3138121A1 (de) 1982-04-15

Similar Documents

Publication Publication Date Title
GB2071500B (en) Coagulator
PH17079A (en) Derivatives of 4-amino-6,7-dimethoxy-2-piperazinoquinoline and compositions thereof
IL69311A0 (en) 2-substituted 4-amino-6,7-dimethoxyquinoline derivatives and pharmaceutical compositions containing them
PH18938A (en) 2-substituted phenyl-4,5,6,7-tetrahydro-2h-indazoles and their use
PH18085A (en) Carbostyril derivatives and cardiotonic compositions containing the same
IL61930A0 (en) 25-hydroxy-26,26,26,27,27,27-hexafluoroch-olecalciferol and derivatives thereof
DE3168891D1 (en) 9-amino-1-hydroxyoctahydrobenzo(c)quinolines and derivatives thereof
PH17562A (en) 2-guanidino-4-heteroarylthiazoles and pharmaceutical compositions
EP0037388A3 (en) Pharmaceutical forms, their preparation and compositions containing the same
DE3068965D1 (en) 6-alpha-fluoro-16-methyl-prednisolone-17,21 diesters and pharmaceutical compositions containing them
PH18605A (en) 3(methylthiomethyl,methylsulphinylmethyl or methylsulphonymethyl) 4 quinolines and therapeutic compositions
PH16982A (en) Penicillanoyloxymethyl penicillanate 1,1,1',1'-tetraoxide and its pharmaceutical composition
IL62660A (en) 4,5-diaryl-alpha(polyfluoroalkyl)-1h-pyrrole-2-methanamines,their preparation and pharmaceutical compositions containing them
PH20791A (en) 2(1h)-pyridinone derivatives,their use and pharmaceutical composition containing them
PH18532A (en) Novel carbostyril derivatives and pharmaceutical compositions containing the same
IT1135680B (it) Procedimento per la manipolazione di prodotti stampati,come pure mezzi e dispositivo per l'esecuzione dello stesso
IL62509A (en) Monohydrated n,n'-bis-(3-picolyl)-4-methoxy-isophthalamide,its preparation and pharmaceutical compositions containing it
PH22848A (en) 3,3-dialkyl- and 3,3,-alkylene-indoline derivatives, pharmaceutical compositions comprising them and their use
GB2092130B (en) 4-oximino-1,2,3,4-tetrahydroquinoline derivatives
JPS56139479A (en) Quinoline derivative, manufacture and medicinal composition containing same
IL62416A (en) 2-butoxy-6-ethyl-2-chloroacetanilides,and herbicidal methods and compositions comprising them
PH16669A (en) Erythromycylamine 11,12-carbonate and derivatives thereof
ZA814392B (en) 1,2,4-triazinylthiomethyl-3-cepheme sulfoxide procedure for preparation and deledic forms
GB2071832B (en) Furnace and the operation thereof
NO156418C (no) FremgangsmŸte for fremstillng av antimikrobielt og antitumorantibiotikum m 9026 og dets rene individuelle faktorer 1, 2 og 3.